FDA.reportPublic FDA data

HLA class II antigen tissue typing IVD, kit, complement-dependent cytotoxicity (CDC)

Definition
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of one or multiple HLA class II antigens in a clinical specimen, using a complement-dependent cytotoxicity (CDC) method.
GUDID devices
1
Last updated
2019-04-02 21:21:59

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
07611969952885Lymphotype HLA-DR/DQ 72Bio-Rad Medical Diagnostics GmbH8231022015-07-01